These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15226691)

  • 1. [Compliance in HIV infected adults. Study of opportunistic infection prophylaxis with cotrimoxazole in Ivory Coast].
    Gourvellec G; Anglaret X; Touré S; Huët C; Dakoury-Dogbo N; Lafont S; N'Dri-Yoman T; Chêne G; Salamon R;
    Presse Med; 2004 May; 33(9 Pt 1):595-600. PubMed ID: 15226691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial.
    Wiktor SZ; Sassan-Morokro M; Grant AD; Abouya L; Karon JM; Maurice C; Djomand G; Ackah A; Domoua K; Kadio A; Yapi A; Combe P; Tossou O; Roels TH; Lackritz EM; Coulibaly D; De Cock KM; Coulibaly IM; Greenberg AE
    Lancet; 1999 May; 353(9163):1469-75. PubMed ID: 10232312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'Ivoire.
    Losina E; Yazdanpanah Y; Deuffic-Burban S; Wang B; Wolf LL; Messou E; Gabillard D; Seyler C; Freedberg KA; Anglaret X
    Antivir Ther; 2007; 12(4):543-51. PubMed ID: 17668563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern of bacterial diseases in a cohort of HIV-1 infected adults receiving cotrimoxazole prophylaxis in Abidjan, Côte d'Ivoire.
    Anglaret X; Messou E; Ouassa T; Toure S; Dakoury-Dogbo N; Combe P; Mahassadi A; Seyler C; N'Dri-Yoman T; Salamon R;
    AIDS; 2003 Mar; 17(4):575-84. PubMed ID: 12598778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Cotrimo-CI Study Group.
    Anglaret X; Chêne G; Attia A; Toure S; Lafont S; Combe P; Manlan K; N'Dri-Yoman T; Salamon R
    Lancet; 1999 May; 353(9163):1463-8. PubMed ID: 10232311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18-month occurrence of severe events among early diagnosed HIV-infected children before antiretroviral therapy in Abidjan, Côte d'Ivoire: a cohort study.
    Harambat J; Fassinou P; Becquet R; Touré P; Rouet F; Dabis F; Msellati P; Blanche S; Timité-Konan M; Salamon R; Leroy V;
    BMC Public Health; 2008 May; 8():169. PubMed ID: 18492259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysis.
    Yazdanpanah Y; Losina E; Anglaret X; Goldie SJ; Walensky RP; Weinstein MC; Toure S; Smith HE; Kaplan JE; Freedberg KA;
    AIDS; 2005 Aug; 19(12):1299-308. PubMed ID: 16052085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of opportunistic diseases on chronic mortality in HIV-infected adults in Côte d'Ivoire.
    Losina E; Anglaret X; Yazdanpanah Y; Wang B; Toure S; Seage GR; N'Dri-Yoman T; Walensky RP; Dakoury-Dogbo N; Goldie SJ; Messou E; Weinstein MC; Deuffic-Burban S; Salamon R; Freedberg KA
    S Afr Med J; 2006 Jun; 96(6):526-9. PubMed ID: 16841136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thresholds of CD4 cells for initiating trimethoprim-sulfamethoxazole prophylaxis in west Africa.
    Anglaret X; Toure S; Ouassa T; Dabis F; N'Dri-Yoman T
    AIDS; 2000 Nov; 14(16):2628-9. PubMed ID: 11101085
    [No Abstract]   [Full Text] [Related]  

  • 10. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
    ; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X
    N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in Côte d'Ivoire.
    Moh R; Danel C; Sorho S; Sauvageot D; Anzian A; Minga A; Gomis OB; Konga C; Inwoley A; Gabillard D; Bissagnene E; Salamon R; Anglaret X
    Antivir Ther; 2005; 10(5):615-24. PubMed ID: 16152755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of cross-sectional anthropometric indices on short-term risk of mortality in human immunodeficiency virus-infected adults in Abidjan, Côte d'Ivoire.
    Castetbon K; Anglaret X; Touré S; Chêne G; Ouassa T; Attia A; N'Dri-Yoman T; Malvy D; Salamon R; Dabis F;
    Am J Epidemiol; 2001 Jul; 154(1):75-84. PubMed ID: 11427407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire.
    Goldie SJ; Yazdanpanah Y; Losina E; Weinstein MC; Anglaret X; Walensky RP; Hsu HE; Kimmel A; Holmes C; Kaplan JE; Freedberg KA
    N Engl J Med; 2006 Sep; 355(11):1141-53. PubMed ID: 16971720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary problems in African HIV-1-infected adults, Abidjan, Côte d'Ivoire. COTRIMO-CI Study Group.
    Castetbon K; Anglaret X; Attia A; Mahassadi A; Malvy D; Dabis F
    J Acquir Immune Defic Syndr; 2000 Apr; 23(4):357-8. PubMed ID: 10836761
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of cotrimoxazole prophylaxis on the incidence of malaria in HIV-infected children in 2012, in Abidjan, Côte d'Ivoire: a prospective cohort study.
    Harouna AM; Amorissani-Folquet M; Eboua FT; Desmonde S; N'Gbeche S; Aka EA; Kouadio K; Kouacou B; Malateste K; Bosse-Amani C; Ahuatchi Coffie P; Leroy V;
    BMC Infect Dis; 2015 Aug; 15():317. PubMed ID: 26248711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of early chemoprophylaxis with co-trimoxazole on nutritional status evolution in HIV-1-infected adults in Abidjan, Côte d'Ivoire.
    Castetbon K; Anglaret X; Attia A; Toure S; Dakoury-Dogbo N; Messou E; N'Dri-Yoman T; Dabis F; Salamon R;
    AIDS; 2001 May; 15(7):869-76. PubMed ID: 11399959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary prevention with cotrimoxazole for HIV-1-infected adults: results of the pilot study in Dakar, Senegal.
    Maynart M; Lièvre L; Sow PS; Kony S; Gueye NF; Bassène E; Metro A; Ndoye I; Ba DS; Coulaud JP; Costagliola D;
    J Acquir Immune Defic Syndr; 2001 Feb; 26(2):130-6. PubMed ID: 11242179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic use of cotrimoxazole against opportunistic infections in HIV-positive patients: knowledge and practices of health care providers in Côte d'Ivoire.
    Brou H; Desgrées-du-Loû A; Souville M; Moatti JP; Msellati P;
    AIDS Care; 2003 Oct; 15(5):629-37. PubMed ID: 12959812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility and effectiveness of cotrimoxazole prophylaxis for HIV-1-infected adults attending an HIV/AIDS clinic in Uganda.
    Watera C; Todd J; Muwonge R; Whitworth J; Nakiyingi-Miiro J; Brink A; Miiro G; Antvelink L; Kamali A; French N; Mermin J
    J Acquir Immune Defic Syndr; 2006 Jul; 42(3):373-8. PubMed ID: 16810124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of cotrimoxazole coadministrated with antituberculous drugs on serum transaminases in HIV-infected adults from the Ivory Coast.
    Messou E; Anglaret X; Bonard D; Kouabena H; N'Dri-Yoman T; Dosso M; Dabis F;
    Br J Clin Pharmacol; 2001 Nov; 52(5):611-2. PubMed ID: 11736872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.